Carmona-Librado R, Escalona-García B, Ramírez-Montiel ML, Casillas-Barrera M, Contreras-Carreto NA

Language: Spanish
References: 14
Page: 203-207
PDF size: 106.96 Kb.

ABSTRACT

Introduction. Diabetes mellitus type 2 (DM2) is a multisystem disease and chronic degenerative multifactorial etiology with varying degrees of hereditary predisposition. It is characterized by hyperglycemia and secondary deficiency in the production or action of insulin. It has an incidence of approximately 3-9% in all pregnancies and is the cause of high maternal and fetal morbidity and mortality. Objective. Describe maternal and fetal morbidity in pregnant patients with DM2 treated at the Hospital de la Mujer. Material and methods. A descriptive, observational, retrospective study of pregnant patients with a history of DM2 treated at the Clinic of Maternal-Fetal, Hospital de la Mujer, Ministry of Health, during the period from 1 May 2009 to 31 May 2011. Results. 43 patients were studied. Age 32.7 ± 5.9 years. Major morbidities detected during was cervicovaginitis (CV) 76.5% (n = 13) followed by threatened abortion 52.9% (n = 9) during the second quarter was 90% CV (n = 9) and preeclampsia/eclampsia 30% (n = 3), during the 3rd quarter urinary tract infection (IVU) 50% (n = 8). The major morbidity was detected fetal welfare loss (PBF) 25% (n = 4) followed by macrosomia 25% (n = 4). Conclusions. Due to the high maternal morbidity and mortality in the presence of DM2 fetal is paramount strict adherence to dietary and drug treatment with close monitoring through prenatal, early detection of micro-and macrovascular complications, screening for metabolic syndrome and other comorbidities that complicate or associated with DM2 without forgetting the mother and infant follow-up.

REFERENCES

1. Pridjian G. Pregestational diabetes. Obstet Gynecol Clin North Am 2010; 37: 143-58.

2. Castorino K, Jovanovic L. Pregnancy and diabetes management: advances and controversies. Clin Chem 2011; 57: 221-30.

3. Sacks DA. Preconception care for diabetic women: background, barriers, and strategies for effective implementation. Curr Diabetes Rev 2006; 2: 147-61.

4. Rehder PM, Pereira BG, Silva JL. Gestational and neonatal outcomes in women with positive screening for diabetes mellitus and 100g oral glucose challenge test normal. Rev Bras Ginecol Obstet 2011; 33: 81-6.

5. Dalfrà MG, Sartore G, Di Cianni G, Mello G, Lencioni C, Ottanelli S, Sposato J, et al. Glucose variability in diabetic pregnancy. Diabetes Technol Ther 2011; 13: 853-9.

6. Powe CE, Thadhani R. Diabetes and the kidney in pregnancy. Semin Nephrol 2011; 31: 59-69.

7. Colatrella A, Braucci S, Festa C, Bianchi P, Fallucca F, Mattei L, Trappolini M, et al. Hypertensive disorders in normal/over-weight and obese type 2 diabetic pregnant women. Exp Clin Endocrinol Diabetes 2009; 117: 373-7.

8. Katon J, Williams MA, Reiber G, Miller E. Antepartum A1C, maternal diabetes outcomes, and selected offspring outcomes: an epidemiological review. Paediatr Perinat Epidemiol 2011; 25: 265-76.

9. García-Patterson A, Aulinas A, Sojo L, Ginovart G, Adelantado JM, de Leiva A, Corcoy R. Poorer perinatal outcome in male newborns of women with pregestational diabetes mellitus. Diabet Med 2011; 28: 436-9.

10. Vitoratos N, Vrachnis N, Valsamakis G, Panoulis K, Creatsas G. Perinatal mortality in diabetic pregnancy. Ann N Y Acad Sci 2010; 1205: 94-8.

11. Rackham O, Paize F, Weindling AM. Cause of death in infants of women with pregestational diabetes mellitus and the relation ship with glycemic control. Postgrad Med 2009; 121: 26-32.

12. Correa A, Gilboa SM, Besser LM, Botto LD, Moore CA, Hobbs CA, Cleves MA, et al. Diabetes mellitus and birth defects. Am J Obstet Gynecol 2008; 199: 237.

13. NOM-015-SSA2-1994. Para la prevención, tratamiento y control de la diabetes. DOF. México, D.F; 16 de octubre de 2000.

14. Hernández-Herrera R, Castillo-Martínez N, Banda-Torres ME, Alcalá-Galván G, Tamez-Pérez HE, Forsbach-Sánchez G. Hipoglucemia neonatal en hijos de madres con diabetes mellitus. Rev Invest Clin 2006; 58: 285-8.